Article Details
Retrieved on: 2019-02-12 03:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Analysts expect Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) to report $-0.75 EPS on March, 12.They anticipate $0.08 EPS change or 11.94% ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here